Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

Rethinking psychotropics in nursing homes

- Featured Image

To the Editor: We thank Hilmer and Gnjidic for highlighting the excessive use of psychotropic medications in Australian nursing homes.1 We recently completed a national psychotropic audit of over 9000 nursing home medication reviews conducted during the 2011–12 financial year. Our results were alarming: even after excluding residents with schizophrenia or bipolar disorder, more than a quarter of residents reviewed (27%) were taking antipsychotics. Concerningly, 41% of all residents reviewed were prescribed benzodiazepines.

Such findings are not new. The problem of excessive psychotropic use in Australian nursing homes has been reported for nearly 20 years and has been the subject of both federal and state inquiries.

As possible solutions, Hilmer and Gnjidic suggest economic evaluations and investment in staff and in research to develop better management strategies.1 Yet, qualitative research has determined that a major reason for high prescribing lies in an overestimation of the efficacy of psychotropic medications and limited awareness of their adverse effects.2 Consequently, awareness-raising and education of health practitioners and residents’…

email